Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia

scientific article published on 01 August 1999

Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1030000132
P356DOI10.1007/S100960050345
P698PubMed publication ID10517190

P50authorAntonio SalarQ42409674
Jordi CarratalaQ56418051
P2093author name stringF Gudiol
J Peris
A Grañena
E González-Barca
A Fernández-Sevilla
P433issue8
P304page(s)539-544
P577publication date1999-08-01
P1433published inEuropean Journal of Clinical Microbiology & Infectious DiseasesQ15754378
P1476titlePrognostic factors influencing mortality in cancer patients with neutropenia and bacteremia
P478volume18

Reverse relations

cites work (P2860)
Q92293429Bacteremia in febrile cancer patients in Uganda
Q36247827Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center
Q45746480Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity
Q40796585Comparison of effectiveness of biosimilar filgrastim (Nivestim™), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study.
Q36870904Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia
Q82508198Different Clinical Characteristics between Polymicrobial and Monomicrobial Aeromonas Bacteremia -A Study of 216 Cases
Q37192118Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the catholic blood and marrow transplantation center.
Q42242524Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
Q34390823European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia
Q34676431Evaluation of febrile neutropenic episodes in adult patients with solid tumors
Q33846201How We Treat Febrile Neutropenia in Patients Receiving Cancer Chemotherapy
Q34614712Incidence of hospital-acquired pneumonia, bacteraemia and urinary tract infections in patients with haematological malignancies, 2004-2010: a surveillance-based study
Q33588190Infection Probability Score, APACHE II and KARNOFSKY scoring systems as predictors of bloodstream infection onset in hematology-oncology patients
Q37345694Lung infections after cancer chemotherapy
Q82323531Meta-Analysis of Randomized Controlled Trials of Granulocyte Colony-Stimulating Factor Prophylaxis in Adult Cancer Patients Receiving Chemotherapy
Q34566114Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
Q34557550Nosocomial infection in adult admissions with hematological malignancies originating from different lineages: a prospective observational study
Q42766829Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy
Q38006021Pharmacoeconomics of the myeloid growth factors: a critical and systematic review
Q54210313Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections.
Q42013683Prognostic indexes of septic syndrome in the emergency department
Q44589566Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center
Q40081509Protocol for Reducing Time to Antibiotics in Pediatric Patients Presenting to an Emergency Department With Fever and Neutropenia: Efficacy and Barriers
Q40212712Role of interleukin-6 in differentiating interleukin-11 induced fever and early bacterial infection
Q36038909Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.

Search more.